Circulating Baseline CXCR3 ⁺ Th2 and Th17 Cell Proportions Correlate With Trabecular Bone Loss After 48 Weeks of Biological Treatment in Early Rheumatoid Arthritis.

Autor: Scheffler JM; University of Gothenburg, Gothenburg, Sweden., Drevinge C; University of Gothenburg, Gothenburg, Sweden., Lindholm C; University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden., Gjertsson I; University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden., Lend K; Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden, and Amsterdam University Medical Center, Amsterdam, the Netherlands., Lund Hetland M; Rigshospitalet, Glostrup, Denmark, and University of Copenhagen, Copenhagen, Denmark., Østergaard M; Rigshospitalet, Glostrup, Denmark, and University of Copenhagen, Copenhagen, Denmark., Uhlig T; Diakonhjemmet Hospital, Oslo, Norway., Schrumpf Heiberg M; Diakonhjemmet Hospital, Oslo, Norway., Haavardsholm EA; Diakonhjemmet Hospital and University of Oslo, Oslo, Norway., Nurmohamed MT; Amsterdam Rheumatology and Immunology Center, Reade, the Netherlands, and Amsterdam University Medical Center, Amsterdam, the Netherlands., Lampa J; Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden., Sokka-Isler T; University of Eastern Finland, Jyväskylä Central Hospital, Jyväskylä, Finland., Nordström D; Helsinki University and University Hospital, Helsinki, Finland., Hørslev-Petersen K; Danish Hospital for Rheumatic Diseases, University Hospital of Southern Denmark, Sønderborg, Denmark, and University of Southern Denmark, Odense, Denmark., Gudbjornsson B; Landspitali National University Hospital of Iceland and University of Iceland, Reykjavik, Iceland., Gröndal G; Landspitali National University Hospital of Iceland and University of Iceland, Reykjavik, Iceland., van Vollenhoven R; Karolinska Institute, Karolinska University Hospital, Stockholm, Sweden, and Amsterdam University Medical Center, Amsterdam, the Netherlands., Carlsten H; University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden., Lorentzon M; University of Gothenburg, Gothenburg, Sweden and Australian Catholic University, Melbourne, Australia., Hultgård Ekwall AK; University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden., Rudin A; University of Gothenburg and Sahlgrenska University Hospital, Gothenburg, Sweden., Islander U; University of Gothenburg, Gothenburg, Sweden.

Publikováno v: ACR open rheumatology [ACR Open Rheumatol] 2024 Oct 16. Date of Electronic Publication: 2024 Oct 16.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

CERTOLIZUMAB-PEGOL, ABATACEPT, TOCILIZUMAB OR ACTIVE CONVENTIONALTHERAPY IN EARLY RHEUMATOID ARTHRITIS: CLINICAL AND RADIOGRAPHIC 48-WEEKS RESULTS OF THE INVESTIGATOR-INITIATED RANDOMIZED NORD-STARTRIAL

Autor: Østergaard, M., Van Vollenhoven, R., Rudin, A., Hetland, M. L., Heiberg, M., Nordström, D., Nurmohamed, M., Gudbjornsson, B., Ørnbjerg, L. Midtbøll, Bøyesen, P., Olsen, I., Lend, K., Hørslev-Petersen, K., Uhlig, T., Sokka-Isler, T., Gröndal, G., Krabbe, S., Lindqvist, J., Gjertsson, I., Glinatsi, D., Kapetanovic, M. C., Aga, A. B., Faustini, F., Parmanne, P., Lorenzen, T., Cagnotto, G., Back, J., Hendricks, O., Vedder, D., Rannio, T., Grenholm, E., Lindegaard, H. M., Ljosa, M. K. A., Brodin, E., Soderbergh, A., Rizk, M., Hermansson, E., Uhrenholt, L., Larsson, P., Just, S. A., Bakland, G., Stevens, D., Laurberg, T. B., Haavardsholm, E. A., Lampa, J.

Publikováno v: Østergaard, M, Van Vollenhoven, R, Rudin, A, Hetland, M L, Heiberg, M, Nordström, D, Nurmohamed, M, Gudbjornsson, B, Ørnbjerg, L M, Bøyesen, P, Olsen, I, Lend, K, Hørslev-Petersen, K, Uhlig, T, Sokka-Isler, T, Gröndal, G, Krabbe, S, Lindqvist, J, Gjertsson, I, Glinatsi, D, Kapetanovic, M C, Aga, A B, Faustini, F, Parmanne, P, Lorenzen, T, Cagnotto, G, Back, J, Hendricks, O, Vedder, D, Rannio, T, Grenholm, E, Lindegaard, H M, Ljosa, M K A, Brodin, E, Soderbergh, A, Rizk, M, Hermansson, E, Uhrenholt, L, Larsson, P, Just, S A, Bakland, G, Stevens, D, Laurberg, T B, Haavardsholm, E A, Lampa, J & NORD-STAR Study Group 2022, ' CERTOLIZUMAB-PEGOL, ABATACEPT, TOCILIZUMAB OR ACTIVE CONVENTIONALTHERAPY IN EARLY RHEUMATOID ARTHRITIS: CLINICAL AND RADIOGRAPHIC 48-WEEKS RESULTS OF THE INVESTIGATOR-INITIATED RANDOMIZED NORD-STARTRIAL ', Annals of the Rheumatic Diseases, vol. 81, no. Suppl. 1, OP0058, pp. 38-40 . https://doi.org/10.1136/annrheumdis-2022-eular.868

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7c7e751a9a992439a5693745cd28ec42
https://vbn.aau.dk/da/publications/1e441a6e-e9f1-4321-8721-8bdfd093d58d

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.